Kiniksa raised its 2025 ARCALYST net sales guidance to $625 million to $640 million, up from prior guidance of $590 million to $605 million. This reflects management's confidence in continued growth ...
Sanj Patel, CEO & Chairman of the Board, stated that "Year-to-date, in 2025, we've continued to execute and meaningfully advance our commercial business and clinical development portfolio." He ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results